What conditions does Clevatess treat?
What conditions does Clevatess treat? Clevatess (estradiol and bazedoxifene) is an FDA-approved hormone therapy specifically designed to treat moderate to severe vasomotor symptoms associated with menopause, commonly known as hot flashes.
Primary Treatment Applications
Menopausal Hot Flashes
Clevatess is primarily prescribed for women experiencing bothersome hot flashes during menopause. The medication combines estradiol, a form of estrogen, with bazedoxifene, a selective estrogen receptor modulator (SERM), to effectively reduce the frequency and severity of these uncomfortable episodes.
Vulvar and Vaginal Atrophy
This combination therapy also treats moderate to severe dyspareunia (painful intercourse) due to vulvar and vaginal atrophy in postmenopausal women. The estradiol component helps restore vaginal tissue health and elasticity, improving comfort and quality of life.
How Clevatess Works
The dual-action formula addresses menopausal symptoms through two mechanisms. Estradiol replaces declining estrogen levels that cause hot flashes and vaginal changes, while bazedoxifene acts as estrogen in some tissues but blocks estrogen effects in breast and uterine tissues, potentially reducing certain hormone-related risks.
Treatment Considerations
Clevatess is specifically indicated for postmenopausal women with an intact uterus. Unlike traditional hormone replacement therapy, this medication doesn't require additional progestin because bazedoxifene provides endometrial protection.
Who Should Consider Clevatess
Women experiencing moderate to severe menopausal symptoms that significantly impact their daily lives may benefit from Clevatess therapy. The medication is particularly suitable for those seeking effective symptom relief without the complexity of multiple hormone medications.
If you're struggling with menopausal symptoms that affect your quality of life, discussing Clevatess with your healthcare provider could help determine if this treatment option aligns with your specific needs and health profile.
Discussion (0)